A Hotter World Means More Disease Outbreaks in Our Future
As global temperatures have risen in recent decades, so have the number of outbreaks of infectious diseases. SARS, MERS, Zika, West Nile, COVID-19, and now clusters of monkeypox and polio have all recently threatened public health. That’s no coincidence. In a study published in August in Nature Climate Change, researchers tried to understand the relationship between major environmental changes related to higher greenhouse gas emissions—including global warming, rising sea levels, storms, floods, drought, and heat waves—and the outbreaks of 375 human infectious diseases caused by viruses, bacteria, and oth...
Source: TIME: Health - August 10, 2022 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized climate change COVID-19 healthscienceclimate Source Type: news

Only Lyme disease vaccine in development goes to Phase 3 trial
Vaccine maker Pfizer says it has begun Phase 3 clinical trial of its vaccine candidate against Lyme disease with French vaccine company Valneva SE. (Source: CNN.com - Health)
Source: CNN.com - Health - August 10, 2022 Category: Consumer Health News Source Type: news

Pfizer Begins Trial for Lyme Disease Vaccine Pfizer Begins Trial for Lyme Disease Vaccine
If the trial succeeds, the vaccine could be the first human vaccine for the tick-borne illness in the US in two decades.WebMD Health News (Source: Medscape PublicHealth Headlines)
Source: Medscape PublicHealth Headlines - August 9, 2022 Category: Primary Care Tags: Infectious Diseases News Source Type: news

Pfizer starts late-stage clinical trials Lyme disease vaccine
A new Lyme disease could be available in the U.S. as early as 2025, as Pfizer has launched final clinical trials for its jab, VLA15. The company is aiming to apply for FDA approval in 2025. (Source: the Mail online | Health)
Source: the Mail online | Health - August 9, 2022 Category: Consumer Health News Source Type: news

States vs Masks; Lyme Vax Trial Begins; Weapons Stockpile in Hospital Closet
(MedPage Today) -- Note that some links may require registration or subscription. A group of 23 state attorneys general led by Florida told a federal court Monday that the CDC does not have the legal authority to impose a nationwide transportation... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - August 9, 2022 Category: American Health Source Type: news

Lyme disease vaccine in late-stage trials would be first in 20 years
If successful, the vaccine would be the first against Lyme disease in the United States since Lymerix, which was discontinued in 2002 because of poor sales. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - August 9, 2022 Category: Consumer Health News Authors: Andrew Jeong Source Type: news

PET scans reveal brain activity related to menopause
PET scans have demonstrated for the first time that only women appear to experienc...Read more on AuntMinnie.comRelated Reading: PET brain scans find links to PTSD severity in 9/11 responders PET tracers reveal long-term consequences of brain injuries Preclinical PET study offers better Alzheimer's detection Carbon-11 PET detects brain inflammation after Lyme disease C-11-based PET tracer could benefit arthritis patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 9, 2022 Category: Radiology Source Type: news

Major test of 1st potential Lyme disease vaccine in 20 years begins in U.S., Europe
Pfizer and French biotech company Valneva are seeking volunteers to test their new vaccine against Lyme disease, which could protect both adults and kids as young as five from the tick-borne illness. (Source: CBC | Health)
Source: CBC | Health - August 9, 2022 Category: Consumer Health News Tags: News/Health Source Type: news

Major test of first possible Lyme vaccine in 20 years begins
Researchers are seeking thousands of volunteers in the U.S. and Europe. (Source: ABC News: Health)
Source: ABC News: Health - August 8, 2022 Category: Consumer Health News Tags: Health Source Type: news

Pfizer tests vaccine to fend off spread of tick-borne Lyme disease
US drugmaker and French partner begin late-stage trial with 14% of global population showing evidence of infection (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - August 8, 2022 Category: Pharmaceuticals Source Type: news

Insurance Data Shows Rise in Lyme Disease in USA
Insurance Data Shows Big Rise in Lyme Disease in US (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - August 4, 2022 Category: General Medicine Source Type: news

Insurance Data Shows Big Rise in Lyme Disease in US Insurance Data Shows Big Rise in Lyme Disease in US
The trends show that tick-borne illnesses are becoming a more common concern nationally, not just in the areas where Lyme disease has been found historically.WebMD Health News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - August 4, 2022 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news

Mayo Clinic Minute: What to do if you are exposed to Lyme disease
Scientists are studying why tick-borne infections, including Lyme disease, are on the rise and why ticks are expanding into new geographic areas. Lyme disease, the most common tick-borne infection, is caused by the bacteria Borrelia burgdorferi and Borrelia mayonii. It's transmitted by the bite of an infected blacklegged tick, previously known as a deer tick. The Northeast and Upper Midwest are hot spots for Lyme disease, though there are other parts of the U.S. and the world… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - July 5, 2022 Category: Databases & Libraries Source Type: news

Economic Burden of Lyme Disease in High-Incidence Areas Economic Burden of Lyme Disease in High-Incidence Areas
An economic evaluation of the costs associated with Lyme disease underscores the importance of effective prevention measures.Emerging Infectious Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 23, 2022 Category: Consumer Health News Tags: Infectious Diseases Journal Article Source Type: news

Pfizer buys stake in French vaccine maker Valneva
US pharma group to pay €90.5mn for 8% in deal that will boost joint Lyme disease programme (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - June 20, 2022 Category: Pharmaceuticals Source Type: news